Not applicableNo Longer AvailableNCT02389933
What this trial is testing
Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF)
Who this might be right for
Heart Failure With Reduced Ejection Fraction (HF-rEF)
Novartis Pharmaceuticals